Maynard Um
-
-
-
-
-
-
-
C4 Therapeutics, Inc. (CCCC) Misses Q3 EPS by 3c
-
-
-
-
-
-
-
C4 Therapeutics, Inc. (CCCC) Tops Q1 EPS by 9c
-
-
-
-
-
-
-
C4 Therapeutics (CCCC) Presents Monotherapy Data Demonstrating Proof of Mechanism and Early Evidence of Proof of Concept From Ongoing CFT1946 Phase 1 Trial
-
-
-
-
-
-
-
C4 Therapeutics (CCCC) Appoints Ron Cooper as Board Chair
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

